Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypanosomes possess a unique set of DNA-associated enzymes essential for the maintenance, replication, and repair of their kinetoplast DNA (kDNA). These enzymes include specialized DNA polymerases (Pol β, Pol β-PAK, POLIA, POLIB, POLIC, POLID), PIF1-like helicases (TbPIF2), and Ribonuclease H2A (TbRH2A) involved in nucleotide metabolism and genome integrity. They ensure accurate replication of minicircles and maxicircles, repair oxidative lesions, and maintain mitochondrial genome stability, vital for parasite survival. Several enzymes are considered promising drug targets due to their parasite-specific features.
Inhibition of DNA replication and repair pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-Associated Enzymes (Trypanosome) (None).